|
US9409139B2
(en)
|
2013-08-05 |
2016-08-09 |
Twist Bioscience Corporation |
De novo synthesized gene libraries
|
|
CA2975852A1
(en)
|
2015-02-04 |
2016-08-11 |
Twist Bioscience Corporation |
Methods and devices for de novo oligonucleic acid assembly
|
|
WO2016172377A1
(en)
|
2015-04-21 |
2016-10-27 |
Twist Bioscience Corporation |
Devices and methods for oligonucleic acid library synthesis
|
|
AU2016324296A1
(en)
|
2015-09-18 |
2018-04-12 |
Twist Bioscience Corporation |
Oligonucleic acid variant libraries and synthesis thereof
|
|
CN108698012A
(zh)
|
2015-09-22 |
2018-10-23 |
特韦斯特生物科学公司 |
用于核酸合成的柔性基底
|
|
CN108603307A
(zh)
|
2015-12-01 |
2018-09-28 |
特韦斯特生物科学公司 |
功能化表面及其制备
|
|
FI3430030T3
(fi)
|
2016-03-16 |
2024-01-16 |
Immatics Biotechnologies Gmbh |
Transfektoituja t-soluja ja t-solureseptoreita käytettäviksi syöpien immunoterapiassa
|
|
GB201604458D0
(en)
|
2016-03-16 |
2016-04-27 |
Immatics Biotechnologies Gmbh |
Peptides and combination of peptides for use in immunotherapy against cancers
|
|
CA3034769A1
(en)
|
2016-08-22 |
2018-03-01 |
Twist Bioscience Corporation |
De novo synthesized nucleic acid libraries
|
|
CN110248724B
(zh)
|
2016-09-21 |
2022-11-18 |
特韦斯特生物科学公司 |
基于核酸的数据存储
|
|
DE102016123847B3
(de)
*
|
2016-12-08 |
2018-04-05 |
Immatics Biotechnologies Gmbh |
Neue T-Zellrezeptoren und deren Verwendung in Immuntherapie
|
|
MY192819A
(en)
|
2016-12-08 |
2022-09-12 |
Immatics Biotechnologies Gmbh |
Novel t cell receptors and immune therapy using the same
|
|
CN110366613A
(zh)
|
2016-12-16 |
2019-10-22 |
特韦斯特生物科学公司 |
免疫突触的变体文库及其合成
|
|
WO2018156792A1
(en)
|
2017-02-22 |
2018-08-30 |
Twist Bioscience Corporation |
Nucleic acid based data storage
|
|
CN110913865A
(zh)
|
2017-03-15 |
2020-03-24 |
特韦斯特生物科学公司 |
免疫突触的变体文库及其合成
|
|
CN111533796A
(zh)
*
|
2017-04-10 |
2020-08-14 |
伊玛提克斯生物技术有限公司 |
用于癌症免疫治疗的肽及其肽组合物
|
|
WO2018231864A1
(en)
|
2017-06-12 |
2018-12-20 |
Twist Bioscience Corporation |
Methods for seamless nucleic acid assembly
|
|
IL271205B2
(en)
|
2017-06-12 |
2025-02-01 |
Twist Bioscience Corp |
Methods for assembling continuous nucleic acids
|
|
US11407837B2
(en)
|
2017-09-11 |
2022-08-09 |
Twist Bioscience Corporation |
GPCR binding proteins and synthesis thereof
|
|
CN111787930B
(zh)
*
|
2017-10-06 |
2024-12-20 |
芝加哥大学 |
针对癌症特异性抗原对t淋巴细胞的筛选
|
|
US12178787B2
(en)
|
2017-10-12 |
2024-12-31 |
Board Of Regents, The University Of Texas System |
T cell receptors for immunotherapy
|
|
KR102637566B1
(ko)
|
2017-10-20 |
2024-02-16 |
트위스트 바이오사이언스 코포레이션 |
폴리뉴클레오타이드 합성을 위한 가열된 나노웰
|
|
CN112041438B
(zh)
|
2018-01-04 |
2025-05-23 |
特韦斯特生物科学公司 |
基于dna的数字信息存储
|
|
GB201803750D0
(en)
|
2018-03-08 |
2018-04-25 |
Immunocore Ltd |
Method
|
|
DE102018108612A1
(de)
|
2018-03-21 |
2019-09-26 |
Immatics US, Inc. |
Verfahren zur erhöhung der persistenz von adoptiv infundierten t-zellen
|
|
WO2019196088A1
(en)
|
2018-04-13 |
2019-10-17 |
Syz Cell Therapy Co. |
Methods of obtaining tumor-specific t cell receptors
|
|
CA3100739A1
(en)
|
2018-05-18 |
2019-11-21 |
Twist Bioscience Corporation |
Polynucleotides, reagents, and methods for nucleic acid hybridization
|
|
JP7558151B2
(ja)
*
|
2018-09-05 |
2024-09-30 |
アダプティミューン・リミテッド |
Ｔ細胞改変
|
|
MX2021003051A
(es)
*
|
2018-09-14 |
2021-05-27 |
Immatics Biotechnologies Gmbh |
Metodo para el cribado de alto desempe?o de la afinidad mhc-peptido para ligandos tcr mediante complejos mhc libres de peptidos estabilizados.
|
|
DE102018122546B3
(de)
|
2018-09-14 |
2019-12-05 |
Immatics Biotechnologies Gmbh |
Verfahren zum Hochdurchsatz-Peptid-MHC-Affinitätsscreening für TCR-Liganden
|
|
CA3124980A1
(en)
|
2018-12-26 |
2020-07-02 |
Twist Bioscience Corporation |
Highly accurate de novo polynucleotide synthesis
|
|
KR20210143766A
(ko)
|
2019-02-26 |
2021-11-29 |
트위스트 바이오사이언스 코포레이션 |
Glp1 수용체에 대한 변이체 핵산 라이브러리
|
|
CN113785057A
(zh)
|
2019-02-26 |
2021-12-10 |
特韦斯特生物科学公司 |
用于抗体优化的变异核酸文库
|
|
US20200297768A1
(en)
|
2019-03-19 |
2020-09-24 |
Immatics US, Inc. |
Cd28 t cell cultures, compositions, and methods of using thereof
|
|
DE102019108125B4
(de)
|
2019-03-28 |
2022-02-03 |
Immatics US, Inc. |
Cd28 t-zellkulturen, zusammensetzungen und verfahren zu deren verwendung
|
|
EP3714941A1
(en)
|
2019-03-27 |
2020-09-30 |
Medigene Immunotherapies GmbH |
Mage-a4 tcrs
|
|
CN111748028A
(zh)
*
|
2019-03-29 |
2020-10-09 |
天津亨佳生物科技发展有限公司 |
一种针对egfr l858r基因突变的特异性t细胞受体及其应用
|
|
CN111748029B
(zh)
*
|
2019-03-29 |
2022-12-13 |
苏州蓝马医疗技术有限公司 |
一种针对egfr l858r基因突变的特异性t细胞受体及其应用
|
|
AU2020267641A1
(en)
*
|
2019-05-08 |
2022-01-06 |
Medigene Immunotherapies Gmbh |
Engineered T cells
|
|
PH12021552979A1
(en)
|
2019-05-27 |
2023-10-09 |
Immatics Us Inc |
Viral vectors and their use in adoptive cellular therapy
|
|
WO2020257288A2
(en)
*
|
2019-06-18 |
2020-12-24 |
Regeneron Pharmaceuticals, Inc. |
Mage-a4 t cell receptors and methods of use thereof
|
|
WO2020257553A1
(en)
*
|
2019-06-20 |
2020-12-24 |
Memorial Sloan-Kettering Cancer Center |
T cell receptors targeting pik3ca mutations and uses thereof
|
|
JP2022550497A
(ja)
|
2019-06-21 |
2022-12-02 |
ツイスト バイオサイエンス コーポレーション |
バーコードに基づいた核酸配列アセンブリ
|
|
CN110357953B
(zh)
*
|
2019-07-17 |
2022-05-03 |
深圳市因诺转化医学研究院 |
识别人巨细胞病毒pp65抗原的TCR
|
|
CN114502580B
(zh)
*
|
2019-07-30 |
2025-10-17 |
大学健康网络 |
Mhc ii类分子及其使用方法
|
|
DE102019121007A1
(de)
*
|
2019-08-02 |
2021-02-04 |
Immatics Biotechnologies Gmbh |
Antigenbindende Proteine, die spezifisch an MAGE-A binden
|
|
US20210032370A1
(en)
|
2019-08-02 |
2021-02-04 |
Immatics Biotechnologies Gmbh |
Recruiting agent further binding an mhc molecule
|
|
CA3155629A1
(en)
|
2019-09-23 |
2021-04-01 |
Twist Bioscience Corporation |
Variant nucleic acid libraries for crth2
|
|
AU2020355027A1
(en)
|
2019-09-23 |
2022-04-21 |
Twist Bioscience Corporation |
Antibodies that bind CD3 Epsilon
|
|
CN115279389A
(zh)
*
|
2020-01-06 |
2022-11-01 |
纪念斯隆-凯特琳癌症中心 |
新型显性负性Fas多肽、包含其的细胞及其用途
|
|
MX2022010461A
(es)
|
2020-02-24 |
2022-12-13 |
Immatics Us Inc |
Metodos para expandir linfocitos t para el tratamiento de cancer y neoplasias malignas asociadas.
|
|
DE102020111571A1
(de)
|
2020-03-11 |
2021-09-16 |
Immatics US, Inc. |
Wpre-mutantenkonstrukte, zusammensetzungen und zugehörige verfahren
|
|
US20220056411A1
(en)
*
|
2020-08-21 |
2022-02-24 |
Immatics US, Inc. |
Methods for isolating cd8+ selected t cells
|
|
EP4227316A4
(en)
*
|
2020-10-07 |
2025-07-30 |
Daan Biotherapeutics Co., Ltd. |
T CELL RECEPTOR, IMMUNE CELL COMPRISING T CELL RECEPTOR, AND METHOD USING THE SAME
|
|
WO2022147029A2
(en)
|
2020-12-31 |
2022-07-07 |
Immatics US, Inc. |
Cd8 polypeptides, compositions, and methods of using thereof
|
|
DE102021100038A1
(de)
|
2020-12-31 |
2022-06-30 |
Immatics US, Inc. |
Modifizierte cd8-polypeptide, zusammensetzungen und verfahren zu deren verwendung
|
|
CN115975003B
(zh)
*
|
2021-03-09 |
2024-01-26 |
科士华(南京)生物技术有限公司 |
Tcr、多肽、表达载体、宿主细胞、药物组合物和tcr获得方法
|
|
WO2022225836A1
(en)
*
|
2021-04-21 |
2022-10-27 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Hla class i-restricted t cell receptors against ras with q61k mutation
|
|
US12162940B2
(en)
|
2021-05-05 |
2024-12-10 |
Immatics Biotechnologies Gmbh |
BMA031 antigen binding polypeptides
|
|
CN113337514B
(zh)
*
|
2021-08-05 |
2021-10-29 |
卡瑞济(北京)生命科技有限公司 |
Tcr表达构建体以及其制备方法和用途
|
|
WO2023044488A1
(en)
|
2021-09-20 |
2023-03-23 |
Immatics US, Inc. |
Monocyte depletion of t cells populations for t-cell therapy
|
|
CN113773378B
(zh)
*
|
2021-10-14 |
2023-11-03 |
深圳大学总医院 |
T细胞受体及其应用
|
|
JP7755062B2
(ja)
*
|
2021-11-03 |
2025-10-15 |
クロン バイオファーマシューティカル （シャンハイ） カンパニー リミテッド |
新規抗ｌ１ｃａｍ抗体
|
|
US20230142468A1
(en)
|
2021-11-08 |
2023-05-11 |
Immatics US, Inc. |
Methods for generating cell spheroids
|
|
EP4448108A1
(en)
|
2021-11-08 |
2024-10-23 |
Immatics Biotechnologies GmbH |
Adoptive cell therapy combination treatment and compositions thereof
|
|
EP4463548A1
(en)
|
2022-01-14 |
2024-11-20 |
Tune Therapeutics, Inc. |
Compositions, systems, and methods for programming t cell phenotypes through targeted gene activation
|
|
EP4463549A2
(en)
|
2022-01-14 |
2024-11-20 |
Tune Therapeutics, Inc. |
Compositions, systems, and methods for programming t cell phenotypes through targeted gene repression
|
|
WO2023148494A1
(en)
*
|
2022-02-03 |
2023-08-10 |
University College Cardiff Consultants Limited |
Novel t-cell receptor
|
|
WO2023183758A2
(en)
*
|
2022-03-19 |
2023-09-28 |
Regeneron Pharmaceuticals, Inc. |
Multispecific molecules targeting cd3 and mage-a4 and uses thereof
|
|
JP2025516189A
(ja)
|
2022-04-28 |
2025-05-27 |
イマティクス ユーエス，アイエヌシー． |
膜結合型ｉｌ－１５、ｃｄ８ポリペプチド、細胞、組成物、およびそれらの使用方法
|
|
US20240066127A1
(en)
|
2022-04-28 |
2024-02-29 |
Immatics US, Inc. |
Il-12 polypeptides, il-15 polypeptides, il-18 polypeptides, cd8 polypeptides, compositions, and methods of using thereof
|
|
EP4514834A1
(en)
|
2022-04-28 |
2025-03-05 |
Immatics US, Inc. |
Dominant negative tgfbeta receptor polypeptides, cd8 polypeptides, cells, compositions, and methods of using thereof
|
|
EP4519418A1
(en)
|
2022-05-05 |
2025-03-12 |
Immatics US, Inc. |
Methods for improving t cell efficacy
|
|
AU2023289164A1
(en)
*
|
2022-06-24 |
2025-01-09 |
Amgen Inc. |
Magea4 specific t cell receptors
|
|
WO2024036166A1
(en)
*
|
2022-08-08 |
2024-02-15 |
The University Of North Carolina At Chapel Hill |
Bioorthogonal t cell receptor molecules and methods of making and using the same
|
|
CN120239746A
(zh)
|
2022-09-19 |
2025-07-01 |
图恩疗法股份有限公司 |
用于调节t细胞功能的组合物、系统和方法
|
|
WO2025029835A1
(en)
|
2023-07-31 |
2025-02-06 |
Tune Therapeutics, Inc. |
Compositions and methods for modulating il-2 gene expression
|
|
WO2025029840A1
(en)
|
2023-07-31 |
2025-02-06 |
Tune Therapeutics, Inc. |
Compositions and methods for multiplexed activation and repression of t cell gene expression
|
|
US20250134931A1
(en)
|
2023-11-01 |
2025-05-01 |
Immatics US, Inc. |
Membrane-bound il-15, cd8 polypeptides, cells, compositions, and methods of using thereof
|
|
WO2025233420A1
(en)
|
2024-05-07 |
2025-11-13 |
Immatics Biotechnologies Gmbh |
Use of anti-cancer molecules
|